Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. DEFA14A Proxy Proxy Materials
  2. DEF 14A Proxy Proxy Statement
  3. 4 Shares withheld for taxes Chief Scientific Officer gave up 16,278 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Commercial Officer gave up 2,451 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Financial Officer gave up 3,457 shares (to pay taxes)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 10-K Report Annual Report
  9. 8-K Event Results of operations · Exit or restructuring costs · Executive or director change
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. 4 Grant or award President & CEO acquired 86,250 shares (grant or award)
  16. 4 Grant or award See Remarks acquired 12,500 shares (grant or award)
  17. 4 Grant or award Chief Scientific Officer acquired 40,000 shares (grant or award)
  18. 4 Grant or award Chief Financial Officer acquired 40,000 shares (grant or award)
  19. SC 13G Stake Amended Statement of Ownership
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 13 of 47 · 923 filings